Multiplex Biomarker Imaging Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017–2025
Global Multiplex Biomarker Imaging Market: Snapshot
In order to detect structural and functional proteins in cells of tissue samples, multiplexed staining technique is a common approach utilized. This technique helps to identify particular stages in which diseases form, thereby obtaining valuable information from the tumor microenvironment. As soon as the multiplex biomarker imaging techniques were introduced in the field of organic chemistry, specifically to map out tumorous cells, an entire new paradigm was created in healthcare services globally.
Biomarker characterization makes it possible to achieve labeling multiple biomarkers regarding the visualization of target proteins in a single tissue section. This helps maximize the amount of information that can be extracted from one characterization attempt. The imaging technology makes use of cellular and morphological structures. In this way, a crystal clear relationship between stromal and immune cells in the tumor microenvironment can be accurately diagnosed.
A strong need for moving on from standard imaging methods such as flow cytometry and other serial methods has caused a great demand for use of the multiplex biomarker imaging technique. This has led to the formation of a distinct global multiplex biomarker imaging market. By implementing this method, highly detailed and more complete information about intact tumor anatomy can be received. This immensely benefits analysts and doctors, thereby driving the global multiple biomarker imaging market in recent times.
From a geographical perspective, this market is mainly spread across Latin America, North America, Africa, Europe, and Asia Pacific. Of these, Asia Pacific depicts the presence of an extensively developed multiple biomarker market, owing to opening up of substantial lucrative avenues, wherein the companies are expected to thrive in future. Furthermore, widespread clinical research on chronic diseases and various cancer types isdriving the growth of this regional market too. Apart from Asia Pacific, North America and Europe also depicts a sizeable presence of the market.
Global Multiplex Biomarker Imaging Market: Overview
Multiplexed staining approaches are used to detect structural and functional proteins in cells in tissue samples helpful in delineating the stage of the diseases and obtain valuable information from the tumor microenvironment. The advent of multiplex biomarker imaging technologies has opened a new paradigm in the comprehensive characterization of tumor cells. The technique has made the labelling multiple biomarkers possible in the visualization of target proteins in a single tissue section, thereby maximizing the amount of information. The imaging technology uses cellular structures and morphological structures. It also helps to uncover relationship between stromal and immune cells in the tumor microenvironment.
Global Multiplex Biomarker Imaging Market: Key Trends
The growing popularity of multiplex biomarker imaging technique stems from the need to get over the limitations of standard methods such as flow cytometry and serial methods, by providing more complete information on the intact tumor anatomy. The need for contextual assessment of the tissue microenvironment, amid constant changes in tissue morphology, is a notable factor fortifying the demand for multiplex biomarker imaging. The demand for these technologies is also gaining traction on account of their role in the development of more efficacious drugs. World over, multiplex biomarker imaging is extensively used in expanding the understanding of cancer biology and for unrevealing the complexity of a range of biological systems.
Global Multiplex Biomarker Imaging Market: Market Potential
Industry players are increasingly focused on finding advanced biomarker techniques for oncology research is also bolstering the uptake. cTA platform and decision support process for tissue biomarkers by a U.S.-based Flagship Biosciences, Inc. were showcased at the American Association for Cancer Research (AACR) Annual Meeting 2018 in April. The platform uses computational analysis to provide quantitative, contextual data on tumor tissue, and is helpful in facilitating clinical trial decisions. Its technical team has also shed light on major developments in immune cell profiling and tumor cell analysis. Pharmaceutical companies around the world can leverage on the potential of the multiplexed biomarker platform to accelerate their efforts in drug development.
In another recent development, Ultivue, Inc., a U.S.-based company developing reagents for high-performance biological system through multiplex biomarker imaging, has in April 2018 unveiled new data on its propriety technology. The technology by the venture-backed company helps in advanced protein biomarker detection with high degree of multiplexing and high imaging throughput. The information released by the biotechnology company underscores the remarkable competency of its biomarker in a wide spectrum of clinical research, including translational research. One of the key benefits of its technology that the company is confident about is the seamless integration with immunohistochemistry workflows. Such developments reiterate the expanding potential of multiplex biomarker imaging techniques.
Global Multiplex Biomarker Imaging Market: Regional Outlook
The study presents a granular assessment of the growth dynamics in various regions and evaluates emerging prospects and lucrative avenues in key ones. Some of the regional markets for multiplex biomarker imaging are North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. Regionally, the Asia Pacific market is emerging at a rapid pace and will present substantially lucrative avenues for companies to capitalize on. Extensive clinical research on chronic diseases and various cancer types is a crucial factor catalyzing the growth of this regional market.
Global Multiplex Biomarker Imaging Market: Competitive Outlook
The study offers a detailed profiling of various players, analyzing their key strategies adopted to gain a firm foothold in the market. The study also takes a critical look at some recent strategic agreements and collaborations made by top players, with an aim to further consolidate their positions in the market. Some of the players holding prominent positions in the global market are Abcam Plc., US Biomax Inc., Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., and PerkinElmer Inc. A number of these players are focusing on developing advanced multiplex biomarker assays.
The study presents a granular assessment and quantitative evaluation of:
The region-wise assessment includes market dynamics in:
The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.
The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:
Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report